Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
The purpose of this study is to estimate the relationship between patient reported outcomes (PROs) and neutropenia (or its complications) in NSCLC subjects receiving chemotherapy with or without Neulasta® (pegfilgrastim).
Epistemonikos ID: a592c93fdcf1bb0c905290e3ba15b9196cd76ca1
First added on: May 04, 2024